Lv1
40 积分 2025-07-31 加入
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
1个月前
已完结
Comparing Sacubitril/Valsartan Against Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure: A Systematic Review and Network Meta-analysis
1个月前
已完结
Effectiveness and safety of angiotensin receptor-neprilysin inhibitor and sodium–glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction: a meta-analysis
2个月前
已完结
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
3个月前
已完结
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction
3个月前
已完结
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
3个月前
已完结
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
3个月前
已完结
A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction
3个月前
已完结
Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China
5个月前
已完结
The Cost-Effectiveness of Dapagliflozin in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: A European Health-Economic Analysis of the DELIVER Trial
7个月前
已完结
皖公网安备34019202002308
